BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12535643)

  • 1. Calcineurin-mediated pathway involved in the differentiated phenotype of smooth muscle cells.
    Ohkawa Y; Hayashi K; Sobue K
    Biochem Biophys Res Commun; 2003 Jan; 301(1):78-83. PubMed ID: 12535643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells.
    Hayashi K; Takahashi M; Kimura K; Nishida W; Saga H; Sobue K
    J Cell Biol; 1999 May; 145(4):727-40. PubMed ID: 10330402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cell activation of the smooth muscle cell phosphoinositide 3-kinase/Akt pathway promotes differentiation.
    Brown DJ; Rzucidlo EM; Merenick BL; Wagner RJ; Martin KA; Powell RJ
    J Vasc Surg; 2005 Mar; 41(3):509-16. PubMed ID: 15838487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique, highly proliferative growth phenotype expressed by embryonic and neointimal smooth muscle cells is driven by constitutive Akt, mTOR, and p70S6K signaling and is actively repressed by PTEN.
    Mourani PM; Garl PJ; Wenzlau JM; Carpenter TC; Stenmark KR; Weiser-Evans MC
    Circulation; 2004 Mar; 109(10):1299-306. PubMed ID: 14993145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cadherin promotes vascular smooth muscle cell dedifferentiation via a GSK3β-inactivation dependent mechanism.
    Frismantiene A; Dasen B; Pfaff D; Erne P; Resink TJ; Philippova M
    Cell Signal; 2016 May; 28(5):516-530. PubMed ID: 26907733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal PTEN inactivation causes proliferation of saphenous vein smooth muscle cells of human CABG conduits.
    Mitra AK; Jia G; Gangahar DM; Agrawal DK
    J Cell Mol Med; 2009 Jan; 13(1):177-87. PubMed ID: 18363844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase.
    Hayashi K; Saga H; Chimori Y; Kimura K; Yamanaka Y; Sobue K
    J Biol Chem; 1998 Oct; 273(44):28860-7. PubMed ID: 9786887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.
    Rommel C; Bodine SC; Clarke BA; Rossman R; Nunez L; Stitt TN; Yancopoulos GD; Glass DJ
    Nat Cell Biol; 2001 Nov; 3(11):1009-13. PubMed ID: 11715022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle-specific overexpression of the type 1 IGF receptor results in myoblast-independent muscle hypertrophy via PI3K, and not calcineurin, signaling.
    Quinn LS; Anderson BG; Plymate SR
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1538-51. PubMed ID: 17940216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of PI-3 kinase/Akt/mTOR, but not calcineurin signaling, reverses insulin-like growth factor I-induced protection against glucose toxicity in cardiomyocyte contractile function.
    Li SY; Fang CX; Aberle NS; Ren BH; Ceylan-Isik AF; Ren J
    J Endocrinol; 2005 Sep; 186(3):491-503. PubMed ID: 16135669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I.
    Imai Y; Clemmons DR
    Endocrinology; 1999 Sep; 140(9):4228-35. PubMed ID: 10465296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo.
    Bodine SC; Stitt TN; Gonzalez M; Kline WO; Stover GL; Bauerlein R; Zlotchenko E; Scrimgeour A; Lawrence JC; Glass DJ; Yancopoulos GD
    Nat Cell Biol; 2001 Nov; 3(11):1014-9. PubMed ID: 11715023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicle-Stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-lnduced kinase (Sgk): evidence for A kinase-independent signaling by FSH in granulosa cells.
    Gonzalez-Robayna IJ; Falender AE; Ochsner S; Firestone GL; Richards JS
    Mol Endocrinol; 2000 Aug; 14(8):1283-300. PubMed ID: 10935551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phosphatidylinositol 3-kinase/Akt signaling pathway modulates the endocrine differentiation of trophoblast cells.
    Kamei T; Jones SR; Chapman BM; MCGonigle KL; Dai G; Soares MJ
    Mol Endocrinol; 2002 Jul; 16(7):1469-81. PubMed ID: 12089343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation.
    Wilson EM; Tureckova J; Rotwein P
    Mol Biol Cell; 2004 Feb; 15(2):497-505. PubMed ID: 14595115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival.
    Zheng WH; Quirion R
    J Neurochem; 2004 May; 89(4):844-52. PubMed ID: 15140184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids.
    Hayashi K; Takahashi M; Nishida W; Yoshida K; Ohkawa Y; Kitabatake A; Aoki J; Arai H; Sobue K
    Circ Res; 2001 Aug; 89(3):251-8. PubMed ID: 11485975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ang II attenuates IGF-1-stimulated Na+, K(+)-ATPase activity via PI3K/Akt pathway in vascular smooth muscle cells.
    Isenovic ER; Meng Y; Jamali N; Milivojevic N; Sowers JR
    Int J Mol Med; 2004 Jun; 13(6):915-22. PubMed ID: 15138635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase-induced smooth muscle cell migration requires PI3-K and Akt activation.
    Galaria II; Nicholl SM; Roztocil E; Davies MG
    J Surg Res; 2005 Jul; 127(1):46-52. PubMed ID: 15964303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity.
    Conover CA; Bale LK; Durham SK; Powell DR
    Endocrinology; 2000 Sep; 141(9):3098-103. PubMed ID: 10965879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.